CompaniesAgalimmune

Agalimmune

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

38

By Phase

PHASE1/PHASE2: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
Today
NCT03593226
Hover over trial bars to see details

Recent Trials

NCT03593226Lead Sponsor
Study to Evaluate Safety & Tolerability of AGI-134 in Solid Tumour
PHASE1/PHASE2Completed
38 participants
Started: Nov 30, 2018 · Completed: Dec 31, 2023
Related Companies
Biolinerx
acquired